Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Anemia, Refractory, with Excess of Blasts 50Myelodysplastic Syndromes 40Leukemia, Myeloid, Acute 34Leukemia, Myelomonocytic, Chronic 33Leukemia 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myeloproliferative Disorders 18Congenital Abnormalities 17Leukemia, Lymphocytic, Chronic, B-Cell 16Anemia, Refractory 15Blast Crisis 14Anemia 14Myelodysplastic-Myeloproliferative Diseases 10Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Myeloid, Accelerated Phase 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Neoplasms 8Lymphoma, Follicular 8Lymphoma 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Monocytic, Acute 8Anemia, Aplastic 8Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Thrombocytopenia 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenoviridae Infections × Classical hematology × Clear all
NCT02231853 2019-12-17

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
12 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adenoviridae Infections, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡